Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10686	Companies
228210	Keywords
156650	Articles
120960	Press releases

Home
Companies
Theranexus

BRIEF

published on 06/23/2026 at 18:05, 12 days 21 hours ago

THX Pharma Welcomes Sophie Jacq Lapointe to its Board of Directors

Board Of Directors Pharmaceutical Strategy THX Pharma International Marketing Sophie Jacq Lapointe
BRIEF

published on 06/23/2026 at 18:05, 12 days 21 hours ago

THX Pharma Appoints Sophie Jacq Lapointe to Board of Directors

Board Of Directors Rare Diseases Pharmaceutical Strategy THX Pharma Sophie Jacq Lapointe
PRESS RELEASE

published on 06/23/2026 at 18:00, 12 days 21 hours ago

THX Pharma Announces the Appointment of Sophie Jacq Lapointe to its Board of Directors
Sophie Jacq Lapointe, an experienced leader in pharmaceuticals and biotechnology, joins THX Pharma's Board of Directors to drive growth and development of rare disease treatments

Biotechnology Pharmaceutical Rare Diseases THX Pharma Sophie Jacq Lapointe
BRIEF

published on 06/16/2026 at 08:05, 20 days 7 hours ago

THX Pharma: Allinvest Securities Recommends Buying the Stock

Strategic Partnerships Biopharmaceutical Rare Diseases AllInvest Securities THX Pharma
BRIEF

published on 06/16/2026 at 08:05, 20 days 7 hours ago

Allinvest Securities Backs THX Pharma with Optimistic Buy Recommendation

Buy Recommendation Partnerships Rare Diseases AllInvest Securities THX Pharma
PRESS RELEASE

published on 06/16/2026 at 08:00, 20 days 7 hours ago

Allinvest Securities Initiates Analyst Coverage on THX Pharma with Buy Recommendation
THX Pharma (Theranexus) announces analyst coverage by Allinvest Securities recognizing successful transformation into rare-disease platform with buy recommendation and 226% upside potential. Portzamparc also follows THX Pharma

Biopharmaceutical Analyst Coverage Rare Diseases AllInvest Securities THX Pharma
BRIEF

published on 06/09/2026 at 18:05, 26 days 21 hours ago

THX Pharma and Exeltis Achieve Key Milestone for TX01 European Approval

EMA Approval TX01 Paediatric Investigation Plan PUMA Pathway European Market Protection
BRIEF

published on 06/09/2026 at 18:05, 26 days 21 hours ago

THX Pharma and Exeltis receive a positive opinion from the EMA for TX01

PUMA Niemann-Pick C Exeltis THX Pharma PIP
PRESS RELEASE

published on 06/09/2026 at 18:00, 26 days 21 hours ago

THX Pharma (Theranexus) and Exeltis secure EMA approval of the paediatric investigation plan (PIP) for TX01, unlocking the PUMA registration pathway
THX Pharma and Exeltis secure 10 years of European market protection for TX01 in Niemann-Pick type C disease with positive PIP approval by EMA's Paediatric Committee (PDCO), paving the way for PUMA submission

Exeltis TX01 THX Pharma PUMA Submission Paediatric Committee
BRIEF

published on 06/09/2026 at 08:05, 27 days 7 hours ago

Industry stakeholders united to raise awareness of Batten disease

Partnership Clinical Study Awareness Batten Disease THX Pharma

Accesswire

Published on 07/06/2026 at 14:30, 42 minutes ago

As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo
Published on 07/06/2026 at 14:15, 57 minutes ago

Gold Terra Announces C$9.7 Million Life Offering, Including Participation From Strategic Shareholder David Harquail
Published on 07/06/2026 at 14:15, 57 minutes ago

Galantas Gold Grants RSUs and Stock Options
Published on 07/06/2026 at 14:00, 1 hour 12 minutes ago

Rio Grande Resources Confirms High-Grade Gold and Silver Including 46.3 g/t Gold and 1,030 g/t Silver in Channel Samples as it Advances Toward Phase 1 Drilling at its Winston Project, New Mexico
Published on 07/06/2026 at 13:15, 1 hour 57 minutes ago

55 North Mining Inc. Announces Name Change to "55 North Gold Inc." and Election of Two New Directors

View all ACCESSWIRE

EQS Group

Published on 07/06/2026 at 15:05, 7 minutes ago

OneLayer Recognized in the Gartner® Hype Cycle™ for Private Networks for Industry, 2026
Published on 07/06/2026 at 15:05, 7 minutes ago

TMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)
Published on 07/06/2026 at 15:00, 12 minutes ago

Hakluyt launches the Hakluyt Essay Prize in collaboration with the Times Literary Supplement
Published on 07/06/2026 at 14:35, 37 minutes ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.74 Million Tokens, and Total Crypto and Total Cash Holdings of $11.1 Billion
Published on 07/06/2026 at 14:25, 47 minutes ago

Circus Appoints Former Aviation and Automotive Executive as New Co-CEO/CFO

Les Echos

Published on 07/06/2026 at 10:59, 4 hours 13 minutes ago

Statement of transactions in own shares from June 29, 2026 to July 3, 2026
Published on 07/06/2026 at 10:52, 4 hours 20 minutes ago

voting rights
Published on 07/06/2026 at 08:00, 7 hours 12 minutes ago

EURAZEO CLOSES FIFTH-GENERATION SECONDARIES PROGRAMME AT €2.3 BILLION, EXCEEDING TARGET
Published on 07/06/2026 at 07:00, 8 hours 12 minutes ago

Thales to acquire the Gorgé family’s stake in Exail with a view to launching a tender for 100% of the company
Published on 07/03/2026 at 21:49, 2 days 17 hours ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.

View all LES ECHOS COMFI WIRE